IDXX vs SREA
IDEXX Laboratories Inc (IDXX) versus DBA Sempra 5.750% Junior Subordinated Notes due 2079 (SREA) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
DBA Sempra 5.750% Junior Subordinated Notes due 2079 (SREA) common stock listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
SREA does not have a complete income-statement cache yet.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. SREA currently screens at market cap $0.
Not investment advice. Open the IDXX and SREA stock pages for the full models.
Not investment advice.